94 results
Page 4 of 5
6-K
EX-99.2
1gw9qj3q2pp xjith
14 Nov 19
Current report (foreign)
4:05pm
6-K
EX-99.1
ar8yv5 5lphd
13 Sep 19
Open Market Sale Agreementsm
5:28pm
SUPPL
c8x6z8yh
13 Sep 19
Supplemental materials (foreign)
5:05pm
6-K
EX-99.3
981hnu
6 Aug 19
Current report (foreign)
4:06pm
6-K
EX-99.1
etul2kqd 10wfk1vcb
18 Jul 19
Aurinia Pharmaceuticals Inc. 6-K
6:30am
6-K
EX-99.1
66raz53nm95cnd17xr
27 Jun 19
Dissident Withdraws the Consents of its Nominees from Consideration Prior to the AGM
12:00am
6-K
EX-99.1
nif0p3gdocv7tduj26ht
21 Jun 19
Shareholders can vote the YELLOW proxy even if they previously voted on the green proxy
6:30am
6-K
EX-99.1
e7izehnoc8mfdz19igs
7 Jun 19
Aurinia Issues Letter to Shareholders
8:00am
6-K
EX-99.2
ypftgs
31 May 19
Notice of Annual General Meeting of Shareholders
8:26am
6-K
EX-99.2
gnmk2xx1e68zykagd
14 May 19
Current report (foreign)
4:04pm
40-F
EX-99.3
o3b53 63xf0kz0o5zfyn
19 Mar 19
Annual report (Canada)
4:16pm
40-F
EX-99.1
w7zhgmr8ut90kvmk
19 Mar 19
Annual report (Canada)
4:16pm
6-K
EX-99.1
89wl 5udjow9zb5e
25 Feb 19
Aurinia Pharmaceuticals Inc. 6-K
7:00am
6-K
EX-99.2
4ryb2yikl x7
30 Nov 18
Current report (foreign)
5:27pm
SUPPL
4u5ttm5 4ok
30 Nov 18
Supplemental materials (foreign)
5:23pm
6-K
EX-99.2
wsu951ov4y
8 Nov 18
Current report (foreign)
4:04pm
6-K
EX-99.2
pl724spr
9 Aug 18
Current report (foreign)
4:05pm
6-K/A
EX-99.3
yuakslnhvje1h9807ra
17 May 18
Current report (foreign) (amended)
12:00am
6-K
EX-99.2
j4ql7gypamdetmnq
10 May 18
Current report (foreign)
4:06pm
6-K
EX-99.1
dzp24242dcfzdxr6zvc
20 Oct 17
Aurinia to Expand Renal Franchise with Novel Indications and Launches Development Program for Treatment of Dry Eye Syndrome
12:00am